Independent peptide directory and research resource
Find a peptide clinic, and know what it actually publishes
190 clinic records across 44 states, each read off the clinic’s own website with the date recorded. Plus evidence-based guides to the substances, and a transparency review of laboratory suppliers.
No paid placements
Every field sourced and dated
Nothing ranked or scored
How this catalogue works
We record facts with sources and dates, and we mark the difference between something we read and something we confirmed. Nothing here is scored, ranked, or for sale.
Read the methodThree steps
1
Search your area
Enter a city or ZIP code to see the clinics we hold records for in that market.
2
Compare providers
Consultation format, the clinicians a clinic names, any price it publishes, and the date we read each detail.
3
Contact a clinic
Send a short request directly. Treatment decisions stay between you and a licensed clinician.
PeptideCare Finder is an independent directory and educational resource. It is not a healthcare provider or pharmacy and does not provide medical advice. Listings are informational and do not constitute endorsement.
Coverage, honestly drawn
Where we actually hold records
Every square is one jurisdiction, drawn the same size, because this is a count of records and not a map of land. The darker a square, the more clinics we hold there. A dashed square means we hold nothing yet, and we would rather show you that than leave it off.
Clinic records 190
Jurisdictions 44/51
Markets 80
What a clinic tells you before you call it
These are counts across every record in the catalogue, taken from what each clinic publishes on its own site. The gaps are the finding: a third of them advertise prescription treatment without naming a single clinician.
Names at least one clinician 150 / 190
The rest advertise prescription services with no clinician named anywhere on the site.
Publishes any price 38 / 190
A figure of any kind — a consultation fee, a monthly range, a membership. Most publish nothing.
Publishes a licence number or NPI 0 / 190
Not one clinic in the catalogue. Every licence on this site is unverified, and every page says so.
Peptide therapy by metropolitan market
All 80 markets →
Browse by treatment interest
Categories reflect services that listed providers publish. Availability requires medical evaluation and varies by clinic and state.
Peptide therapy
Clinician-supervised programs, evaluation and monitoring.
Medical weight management
Physician-led programs including prescription options.
GLP-1 care
Approved GLP-1 medicines and what compounded means.
Recovery support
What clinics offer, and where human evidence is thin.
Longevity medicine
Preventive and metabolic practices with clinician oversight.
Hormone optimization
Endocrine evaluation, labs and follow-up requirements.
Four regulatory statuses, kept separate everywhere on this site
Every peptide named on this site carries one of these labels. The label describes regulatory status only. It is not a statement about how well a substance works.
Approved
FDA-approved for a specific indication
The medicine has been evaluated and approved for a named use, in a named population, at a named dose.
Off-label
Prescribed off-label
An approved medicine used for something outside its approval. Legal for a clinician to prescribe; evidence varies by use.
Compounded
Compounded medication
Prepared by a pharmacy for an individual patient. Compounded drugs are not FDA-approved and are not reviewed for safety or effectiveness.
Investigational
Investigational or not approved
Studied but not approved for the use commonly marketed. Human evidence is limited or absent.
Separate editorial section · laboratory research suppliers
Research supplier reviews
Independent reviews of supplier transparency, lot documentation, laboratory reports, business policies and regulatory history. Supplier scores do not indicate that a product is safe or appropriate for human use.
14 documents
FDA warning-letter archive
Every FDA warning letter to a peptide seller, with the products named exactly as FDA writes them and a link to the official document.
11 checks
How to read a certificate of analysis
What a COA can establish, what it cannot, and the inferences commonly drawn from one that it does not support.
Updated
What the July 2026 FDA vote did
The advisory committee considered seven peptides for compounding. A recommendation is not an approval — and the use FDA evaluated is often not the use marketed.
Products labeled for research use are not approved for personal, medical or veterinary use. Nothing in this section establishes that any product is safe, sterile, accurately labeled or suitable for human use. Looking for peptide treatment? Find a licensed clinic instead.
Medical editorial standards
- Every medical guide names a writer and a licensed clinical reviewer.
- Regulatory status is verified against primary agency sources before publication.
- Animal, in-vitro and anecdotal findings are never described as human benefit.
- No dosing, reconstitution, cycling or self-injection guidance is published.
- Corrections are dated and logged in the page's change history.
Latest medically reviewed guides
2026-07-22 FDA-approved versus compounded peptide medicines Editorial team · sourced to primary documents 2026-07-09 What peptide therapy costs, and what the price usually excludes Editorial team · sourced to primary documents 2026-06-28 Why a compounded GLP-1 is cheaper, and what that price buys Editorial team · sourced to primary documents 2026-06-14 Peptide therapy safety: what is known and what is not Editorial team · sourced to primary documents
Directory and review updates
Monthly summary of new provider verifications, updated supplier reviews and regulatory actions. No treatment advice, no product promotion.